SEC EDGAR Filing Information

Form DFAN14A -- Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material

Filing Date Changed: 2009-05-07
Effectiveness Date: 2009-05-07
Documents: 1

SEC Accession No.
0001193125-09-103620
Filing date: 2009-05-07
Accepted: 2009-05-07 17:30:06

Table of submitted documents:

Seq	Type	Document	Size	Description
1	DFAN14A	ddfan14a.htm	15027	DEFINITIVE ADDITIONAL MATERIALS

		0001193125-09-103620.txt	17000	Complete submission text file

Filer Information:

AMYLIN PHARMACEUTICALS INC (Subject) (0000881464)
IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFAN14A | Act: 34 | File No.: 000-19700 | Film No.: 09806880
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
9360 TOWNE CENTRE DR
SUITE 110
SAN DIEGO CA 92121
6195522200

Mailing Address
9360 TOWNE CENTRE DR
SUITE 110
SAN DIEGO CA 92121

EASTBOURNE CAPITAL MANAGEMENT LLC/CA (Filed by) (0001140888)
IRS No.: 000000000 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DFAN14A | Act: | Film No.:

Business Address
1101 FIFTH AVENUE
SUITE 370
SAN RAFAEL CA 94901
4154481200

Mailing Address
1101 FIFTH AVENUE
SUITE 370
SAN RAFAEL CA 94901